Response to steroids in de novo autoimmune hepatitis after liver transplantation

Hepatology

Volumn 35, Issue 2, 2002, Pages 349-356

  Salcedo, Magdalena ^a   Vaquero, Javier ^a   Bañares, Rafael ^a   Rodríguez Mahou, Margarita ^a   Alvarez, Emilio ^a   Vicario, Jose Luis ^b   Hernández Albújar, Alicia ^a   Tíscar, José Luis R ^a   Rincón, Diego ^a   Alonso, Sonia ^a   de Diego, Alejandro ^a   Clemente, Gerardo ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b Regional Transfusion Center   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AZATHIOPRINE; CYCLOSPORIN; HLA ANTIGEN; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; PREDNISOLONE; PREDNISONE; STEROID; TACROLIMUS;

ADULT; ARTICLE; AUTOIMMUNE HEPATITIS; BLOOD DONOR; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DRUG RESPONSE; FEMALE; FOLLOW UP; GRAFT REJECTION; HISTOPATHOLOGY; HLA SYSTEM; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY INFILTRATE; LIVER NECROSIS; LIVER TRANSPLANTATION; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RELAPSE; STEROID THERAPY;

EID: 18244397464     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2002.31167     Document Type: Article

References (50)

1. De novo autoimmune hepatitis after liver transplantation
2. Autoimmune mediated liver disease after liver transplantation (LT)
3. International Autoimmune Hepatitis Group Report: Review of criteria for diagnosis of autoimmune hepatitis
4. Immunofluorescent test for the detection of autoantibodies
5. Antibody to liver cytosol (anti LC-1) in patients with autoimmune chronic hepatitis type 2
6. Autoimmune manifestations in children transplanted for non-autoimmune liver diseases
7. Development of autoimmune hepatitis following liver transplantation for primary biliary cirrhosis
8. Concurrent De Novo autoimmune hepatitis and recurrence of primary biliary cirrhosis post-liver transplantation
9. De Novo Autoimmune hepatitis (AIH) after liver transplantation (LT)
10. Response to steroid treatment in "de novo" autoimmune hepatitis after liver transplantation in adults
11. Recurrent autoimmune hepatitis after liver transplantation: Diagnostic criteria, risk factors, and outcome
12. Recurrent autoimmune hepatitis after liver transplantation - When non-self becomes self
13. Autoimmune hepatitis following hepatitis A virus infection
14. Autoimmune hepatitis type 2 induced by HCV and persisting after viral clearance
15. Autoimmune hepatitis and adrenal insufficiency in an infant with human herpes, virus-6 infection
16. Epstein-Barr virus as a trigger for autoimmune hepatitis in susceptible individuals
17. Autoimmune hepatitis type 1 after measles
18. Short analytical review. AIDS virus infection and autoimmunity: A perspective of the clinical, immunological and molecular origins of the autoallergic pathologies associated with HIV disease
19. Short analytical review. Autoreactivity in HIV-1 infection: The role of molecular mimicry
20. Nephrotic syndrome in a patient with IgA deficiency-associated mesangioproliferative glomerulonephritis
21. Serum autoantibodies after liver transplantation. Prevalence and associated immunologic disorders
22. Autoimmunity after allogeneic bone marrow transplantation. A study of 53 long-term-surviving patients
23. Autoantibodies to nuclear, cytoplasmic and cytoskeletal antigens in renal allograft rejection
24. Tolerance and autoimmunity
25. De novo autoimmunity to cardiac myosin after heart transplantation and its contribution to the rejection process
26. Development of cytochrome P450 2D6-specific LKM-autoantibodies following liver transplantation for Wilson's disease-possible association with a steroid-resistant transplant rejection episode
27. Autoantibodies associated with acute rejection after liver transplantation for type-2 autoimmune hepatitis
28. Cytomegalovirus-induced CD 13-specific autoimmunity - A possible cause of chronic graft-versus-host disease
29. CD 13-specific autoimmunity in cytomegalovirus-infected immunocompromised patients
30. Pathogenesis of Cyclosporine A-induced autoimmunity: Absence of T-cell reactivity towards syngenic antigen presenting cell
31. Cyclosporine-induced autoimmunity: Critical role of autoregulation in the prevention of major histocompatibility class-II dependent autoaggression
32. Immune mechanisms in cyclosporine-induced syngenic graft-versus-host disease
33. Graft-versus-host disease in cyclosporine A-treated rats after syngenic and autologous bone marrow reconstitution
34. The lesions of cyclosporine-induced autoimmune disease can be equally well elicited by CD4 or CD8 effector T cells
35. Regulation of tumor necrosis factor cytotoxicity by calcineurin
36. Suppression or induction of apoptosis by opposing pathways downstream from calcium-activated calcineurin
37. Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD
38. Immunologic tolerance for immune system-mediated diseases. NIAID symposium synopsis
39. Apoptosis: Mechanisms of life and death in the immune system
40. The role of Fas and related death receptors in autoimmune and other disease states
41. Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis
42. Genetic in liver diseases
43. Allelic sequence variation in the HLA class II genes and proteins on patients with autoimmune hepatitis
44. Recurrent autoimmune hepatitis after Orthotopic liver transplantation
45. Susceptibility to autoimmune chronic active: Human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors
46. The relationship between autoimmune markers and different clinical syndromes in autoimmune hepatitis
47. Disease recurrence and rejection following liver transplantation for autoimmune chronic active liver diseases
48. Major histocompatibility complex genes and susceptibility to systemic lupus erythematosus
49. The significance of the association between HLA and multiple sclerosis
50. Graft dysfunction mimicking autoimmune hepatitis following liver transplantation in adults